CNMD – CONMED Corporation
Float Short %
6.95
Margin Of Safety %
20
Put/Call OI Ratio
0.17
EPS Next Q Diff
0.17
EPS Last/This Y
0.18
EPS This/Next Y
0.31
Price
52.91
Target Price
61
Analyst Recom
2.67
Performance Q
-3.77
Relative Volume
0.42
Beta
1.17
Ticker: CNMD
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-08-15 | CNMD | 53.12 | 0.53 | 0.54 | 1672 |
| 2025-08-18 | CNMD | 53.37 | 0.11 | 0.10 | 911 |
| 2025-08-19 | CNMD | 54.54 | 0.12 | 0.00 | 879 |
| 2025-08-20 | CNMD | 53.47 | 0.12 | 0.00 | 877 |
| 2025-08-21 | CNMD | 53.09 | 0.12 | 8.00 | 878 |
| 2025-08-22 | CNMD | 55.81 | 0.12 | 8.00 | 878 |
| 2025-08-25 | CNMD | 54.28 | 0.12 | 8.00 | 878 |
| 2025-08-26 | CNMD | 54.69 | 0.18 | 0.00 | 918 |
| 2025-08-27 | CNMD | 54.42 | 0.18 | 0.00 | 918 |
| 2025-08-28 | CNMD | 53.78 | 0.18 | 0.00 | 918 |
| 2025-08-29 | CNMD | 54.33 | 0.18 | 0.00 | 918 |
| 2025-09-02 | CNMD | 53.52 | 0.17 | 0.00 | 922 |
| 2025-09-03 | CNMD | 52.9 | 0.17 | 0.00 | 956 |
| 2025-09-04 | CNMD | 54.78 | 0.17 | 0.00 | 956 |
| 2025-09-05 | CNMD | 54.99 | 0.17 | 999.99 | 957 |
| 2025-09-08 | CNMD | 53.81 | 0.17 | 0.67 | 965 |
| 2025-09-09 | CNMD | 54.03 | 0.17 | 0.18 | 975 |
| 2025-09-10 | CNMD | 52.78 | 0.17 | 0.00 | 986 |
| 2025-09-11 | CNMD | 54.06 | 0.17 | 0.00 | 986 |
| 2025-09-12 | CNMD | 52.89 | 0.17 | 0.00 | 986 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-08-15 | CNMD | 53.08 | 0.2 | - | 4.47 |
| 2025-08-18 | CNMD | 53.38 | 0.2 | - | 4.47 |
| 2025-08-19 | CNMD | 54.50 | 0.2 | - | 4.47 |
| 2025-08-20 | CNMD | 53.45 | 0.2 | - | 4.47 |
| 2025-08-21 | CNMD | 53.10 | 0.2 | - | 4.47 |
| 2025-08-22 | CNMD | 55.78 | 0.2 | - | 4.47 |
| 2025-08-25 | CNMD | 54.28 | 0.2 | - | 4.47 |
| 2025-08-26 | CNMD | 54.73 | 0.2 | - | 4.47 |
| 2025-08-27 | CNMD | 54.38 | 0.2 | - | 4.47 |
| 2025-08-28 | CNMD | 53.78 | 0.2 | - | 4.47 |
| 2025-08-29 | CNMD | 54.33 | 0.2 | - | 4.47 |
| 2025-09-02 | CNMD | 53.55 | 0.2 | - | 4.47 |
| 2025-09-03 | CNMD | 52.76 | 0.2 | - | 4.47 |
| 2025-09-04 | CNMD | 54.69 | 0.2 | - | 4.47 |
| 2025-09-05 | CNMD | 54.97 | 0.2 | - | 4.47 |
| 2025-09-08 | CNMD | 53.83 | 0.2 | - | 4.47 |
| 2025-09-09 | CNMD | 53.99 | 0.2 | - | 4.47 |
| 2025-09-10 | CNMD | 52.82 | 0.2 | - | 4.47 |
| 2025-09-11 | CNMD | 54.05 | 0.2 | - | 4.47 |
| 2025-09-12 | CNMD | 52.91 | 0.2 | - | 4.47 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-08-15 | CNMD | -0.57 | -1.73 | 6.95 |
| 2025-08-18 | CNMD | -0.57 | -3.50 | 6.95 |
| 2025-08-19 | CNMD | -0.57 | -3.50 | 6.97 |
| 2025-08-20 | CNMD | -0.52 | -3.50 | 6.97 |
| 2025-08-21 | CNMD | -0.52 | -3.50 | 6.97 |
| 2025-08-22 | CNMD | -0.52 | -3.50 | 6.97 |
| 2025-08-25 | CNMD | -0.52 | -1.96 | 6.97 |
| 2025-08-26 | CNMD | -0.52 | -1.96 | 6.97 |
| 2025-08-27 | CNMD | -0.52 | -1.96 | 6.58 |
| 2025-08-28 | CNMD | -0.52 | -1.96 | 6.58 |
| 2025-08-29 | CNMD | -0.52 | -1.96 | 6.58 |
| 2025-09-02 | CNMD | -0.52 | -1.88 | 6.58 |
| 2025-09-03 | CNMD | -0.52 | -1.88 | 6.58 |
| 2025-09-04 | CNMD | -0.52 | -1.88 | 6.58 |
| 2025-09-05 | CNMD | -0.52 | -1.88 | 6.58 |
| 2025-09-08 | CNMD | -0.52 | -1.91 | 6.58 |
| 2025-09-09 | CNMD | -0.52 | -1.91 | 6.58 |
| 2025-09-10 | CNMD | -0.52 | -1.91 | 6.58 |
| 2025-09-11 | CNMD | -0.52 | -1.91 | 6.95 |
| 2025-09-12 | CNMD | -0.52 | -1.91 | 6.95 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.15
Avg. EPS Est. Current Quarter
1.05
Avg. EPS Est. Next Quarter
1.32
Insider Transactions
-0.52
Institutional Transactions
-1.91
Beta
1.17
Average Sales Estimate Current Quarter
334
Average Sales Estimate Next Quarter
369
Fair Value
63.52
Quality Score
77
Growth Score
75
Sentiment Score
22
Actual DrawDown %
66.8
Max Drawdown 5-Year %
-68.7
Target Price
61
P/E
14.94
Forward P/E
11.16
PEG
1.74
P/S
1.24
P/B
1.63
P/Free Cash Flow
11.05
EPS
3.54
Average EPS Est. Cur. Y
4.47
EPS Next Y. (Est.)
4.78
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
8.33
Relative Volume
0.42
Return on Equity vs Sector %
-13.9
Return on Equity vs Industry %
-7.6
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.06
EBIT Estimation
CONMED CorporationSector: Healthcare
Industry: Medical Devices
Employees: 3900
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, the company offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention; and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.
stock quote shares CNMD – CONMED Corporation Stock Price stock today
news today CNMD – CONMED Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch CNMD – CONMED Corporation yahoo finance google finance
stock history CNMD – CONMED Corporation invest stock market
stock prices CNMD premarket after hours
ticker CNMD fair value insiders trading